City
Epaper

Study suggests medical cannabis helpful in reducing blood pressure

By ANI | Published: February 14, 2021 11:16 PM

The findings of a new study by researchers from Ben-Gurion University of the Negev (BGU) and its affiliated Soroka University Medical Center, suggests that medical cannabis may help in reducing blood pressure in older adults.

Open in App

The findings of a new study by researchers from Ben-Gurion University of the Negev (BGU) and its affiliated Soroka University Medical Center, suggests that medical cannabis may help in reducing blood pressure in older adults.

The study, published in the 'European Journal of Internal Medicine', is the first of its kind to focus on the effect of cannabis on blood pressure, heart rate, and metabolic parameters in adults 60 and above with hypertension.

"Older adults are the fastest-growing group of medical cannabis users, yet evidence on cardiovascular safety for this population is scarce," said Dr Ran Abuhasira of the BGU Faculty of Health Sciences, one of Israel's leading medical faculties, and the BGU-Soroka Cannabis Clinical Research Institute.

"This study is part of our ongoing effort to provide clinical research on the actual physiological effects of cannabis over time," added Dr Abuhasira.

Patients were evaluated using 24-hour ambulatory blood pressure monitoring, ECG, blood tests, and body measurements -- both before and three months after initiating cannabis therapy.

In the study, researchers found a significant reduction in 24-hour systolic and diastolic blood pressure values, with the lowest point occurring three hours after ingesting cannabis either orally via oil extracts or by smoking. Patients showed reductions in blood pressure in both daytime and nighttime, with more significant changes at night.

The BGU researchers theorised that the relief from pain, the indication for prescription cannabis in most patients, may also have contributed to a reduction in blood pressure.

"Cannabis research is in its early stages and BGU is at the forefront of evaluating clinical use based on scientific studies," said Doug Seserman, chief executive officer of American Associates, Ben-Gurion University of the Negev.

"This new study is one of several that has been published recently by BGU on the medicinal benefits of cannabis," concluded Seserman.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Ben-gurion university of the negevSoroka university medical centerDoug seserman
Open in App

Related Stories

InternationalChronic pain disorder linked to heightened risk of early death

InternationalIsraeli scientists identify molecule preventing dental cavities

HealthOmicron variant did not eliminate Delta, it may return: Study

TechnologyStudy finds routine prenatal ultrasound identifies autism's early signs

HealthRoutine prenatal ultrasound identifies early signs of autism: Study

Health Realted Stories

HealthLack of education, misconceptions on asthma hindering treatment: Doctors

HealthElderly woman weighing 102 kgs undergoes bilateral knee replacement in Noida

HealthGood News! Scientists Develop All-in-One Vaccine Effective Against Current and Future Coronavirus Variants

HealthAsthma can negatively affect brain functions: Experts

HealthRepurposed cancer drug to help replace insulin therapy for diabetes